Mobile

6-month, open-label, randomized, multicenter, prospective, controlled study to evaluate the efficacy, safety and tolerability of Everolimus in de novo renal transplant recipients participating in the ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-005109-20

6-month, open-label, randomized, multicenter, prospective, controlled study to evaluate the efficacy, safety and tolerability of Everolimus in de novo renal transplant recipients participating in the Eurotransplant senior program

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this trial is to exploratively examine superiority of a treatment regimen with Certican with respect to the renal function at 6 months after renal transplantation (Tx) assessed by glomerular filtration rate (GFR) – Cockcroft-Gault method - as compared to the standard regimen in de novo senior renal transplant recipients

Critère d'inclusion

  • renal transplantation

Liens